TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2024
Back to search
Official data from USPTO
ASPYRERX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
12/24/2024
Trademark type
Word
Nice classes
9
Filing date
03/31/2023
Registration date
04/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
12/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/16/2023
First use in commerce
10/16/2023
Drawing code
4
Owner type
03
Owner location
NEW YORK, NY
Examiner
LINDEMANN, ROBIN
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CLICK THERAPEUTICS, INC.
Better Therapeutics, Inc.
Representatives
Katherine P. Califa Foley & Lardner LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable mobile medical applications (MMA) for the treatment and management of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) prescribed by physicians for the treatment of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) delivering Cognitive Behavioral Therapy (CBT) for the management and treatment of cardiometabolic diseases; Downloadable Software as a Medical Device (SaMD) for the treatment of patients with cardiometabolic diseases and conditions; Downloadable software applicationsdownloadable software for a prescription digital therapeutic providing cognitive behavioral therapy for the treatment of cardiometabolic diseases and conditions; Downloadable software for collecting self-reported biometric data and information from patients for the treatment of cardiometabolic diseases and conditions
Publications
History of USPTO decisions and trademark events.
24 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/18/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/18/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/18/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/18/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/16/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2024
PUBO
PUBLISHED FOR OPPOSITION
02/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/04/2024
IUAA
USE AMENDMENT ACCEPTED
01/04/2024
DOCK
ASSIGNED TO EXAMINER
12/27/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/13/2023
IUAF
USE AMENDMENT FILED
11/13/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2023
NWAP
NEW APPLICATION ENTERED
04/04/2023
Continuous trademark protection
Get notified about every new filing that threatens ASPYRERX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.